Patent 9051367 was granted and assigned to iPierian, Inc. on June, 2015 by the United States Patent and Trademark Office.
The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.